Sperm Precursor Cells Created in Lab
By Michael Cook,
BioEdge
| 09. 07. 2012
The moment when scientists will be able to create artificial sperm from a skin cell is drawing closer. Scientists at the University of Pittsburgh have reported in the journal Cell Reports that they grew precursor sperm cells from induced pluripotent stem cells derived from skin cells.
The immediate use for this is treatment of men who became infertile after treatment for cancer. “Sperm can be banked for future artificial insemination procedures, but that does not help some patients, such as pre-pubertal boys,” Dr Charles Easley, the lead author says. “There are procedures to store testicular tissue prior to cancer therapy, but men who didn’t have the opportunity to save tissue are permanently sterile, and so far there are no cures for their sterility”
Creating sperm cells from stem cells has proved far more difficult than creating heart cells or nerve cells. “No one has been able to make human sperm from pluripotent stem cells in the lab, but this research indicates it might be possible,” Dr Easley says. “This model also gives us a unique opportunity to study the molecular...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...